Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
Conditions
- Cervical Adenocarcinoma
- Cervical Adenosquamous Carcinoma
- Cervical Squamous Cell Carcinoma
- Recurrent Cervical Carcinoma
- Stage IVB Cervical Cancer
Interventions
- BIOLOGICAL: Bevacizumab
- DRUG: Cisplatin
- OTHER: Laboratory Biomarker Analysis
- DRUG: Paclitaxel
- OTHER: Quality-of-Life Assessment
- OTHER: Questionnaire Administration
- DRUG: Topotecan Hydrochloride
Sponsor
National Cancer Institute (NCI)
Collaborators